Experimental Psychology mourns the sudden death of Professor Glyn Humphreys
Psychology has lost a wonderful friend, a caring mentor and a brilliant scientist. Professor Glyn Humphreys died suddenly while in Hong Kong as a Distinguished Visiting Professor. In Oxford he held the Watts Chair of Experimental Psychology and was a transformative Head of Department. He was a world leading authority in cognitive neuropsychology. Among numerous awards and honours, he received the British Psychological Society Lifetime Achievement Award in 2015 in recognition of his exceptional contributions to the field of psychology. Members of the Department of Experimental Psychology have been deeply affected by this extremely sad news. Glyn was so young and so full of life and vitality. Together with his wife and colleague Jane Riddoch they brought both wisdom and experience to Experimental Psychology and the Medical School. Our thoughts are with Jane and their family.
What we provide
INDIREA is a European Marie Curie funded training network which aims to investigate and improve diagnostics and rehabilitation of attentional disorders within neuropsychological populations such as brain injury and neuropsychological diseases.
The training network is set up across six top higher education institutions in Europe, who are hosting thirteen early stage career researchers. Through INDIREA these PhD candidates are being trained in state of the art, advanced training workshops and have the opportunity to collaborate closely within the network as well as with the associated industrial partners in order to capitalise and implement the research outcomes into practical clinical solutions.
This project involves the development of a new and fully integrated approach to understanding and rehabilitation disorders in patients – going from the measurement and modelling of basic brain processes through to the creation of linked, clinically applicable, neuropsychological assessments and attentional training.
The assessments will be closely tied to the rehabilitation procedures, which are designed to re-instate or by-pass the impaired behaviour. The new diagnostic procedures will be developed commercially and the rehabilitation studies will provide experimental tests for larger-scale commercial clinical trials.
PhD programmes linked to the novel assessments and rehabilitation procedures will give students unique breadth of knowledge and also experience in the application of the diagnostic and rehabilitation procedures to industry. The cohort of student will be exceptionally well-placed to make a ‘disruptive’ change in the evaluation and treatment of attentional disorders.
Aims and Objectives
OVERALL AIM 1: to enhance the neuropsychological diagnosis of attentional disorders by linking clinical measures to detailed cognitive models and their associated neural biomarkers, and to develop the diagnostic procedures as commercial tests. This will be realised through 4 specific strategic objectives (SOs).
OVERALL AIM 2: to use advanced neuropsychological measures of attention (OVERALL AIM 1) to design and evaluate individualised rehabilitation for attentional dysfunctions.
OVERALL AIM 3: to provide a new cohort of PhD students with inter-disciplinary scientific and technological skills linked to the generation of commercial outputs.